This is the authors' abstract. We don't add key points for this paper.
Herein we report a practical crystallization-induced diastereomer transformation (CIDT) of oxime isomers for the scalable asymmetric synthesis of the bicyclic diamine (1 S,6 R )-3,9-diazabicyclo[4.2.1]nonane derivative that serves as a valuable building block in medicinal chemistry. The developed approach utilizes ( S )-phenylethylamine as a chiral auxiliary handle for CIDT, and the starting nortropinone derivative is prepared in one step from commercially available materials. The resulting E -oxime is subjected to a stereospecific Beckmann rearrangement, followed by reduction of the resulting lactam with LiAlH 4 to afford the monoprotected (1 S,6 R )-3,9-diazabicyclo[4.2.1]nonane derivative. The development of the CIDT and understanding of the mechanistic implications leading to the high selectivity are reported.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Lisnyak et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: